USD 1.94
(-11.82%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -1.49 USD | 12.35% |
2022 | -1.70 USD | -36.0% |
2021 | -1.25 USD | -98.41% |
2020 | -0.63 USD | -3.28% |
2019 | -0.61 USD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -0.40 USD | 13.04% |
2024 Q1 | -0.46 USD | -24.32% |
2023 Q1 | -0.37 USD | 15.91% |
2023 FY | - USD | 12.35% |
2023 Q3 | -0.36 USD | -2.86% |
2023 Q4 | -0.37 USD | -2.78% |
2023 Q2 | -0.35 USD | 5.41% |
2022 Q2 | -0.31 USD | 3.13% |
2022 Q1 | -0.32 USD | -18.52% |
2022 FY | - USD | -36.0% |
2022 Q4 | -0.44 USD | 10.2% |
2022 Q3 | -0.49 USD | -58.06% |
2021 Q2 | -0.32 USD | -245.95% |
2021 FY | - USD | -98.41% |
2021 Q1 | -0.09 USD | 87.5% |
2021 Q4 | -0.27 USD | 44.9% |
2021 Q3 | -0.49 USD | -53.12% |
2020 Q4 | -0.74 USD | -974.02% |
2020 Q3 | -0.07 USD | 0.0% |
2020 FY | - USD | -3.28% |
2019 FY | - USD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
AIM ImmunoTech Inc. | -0.60 USD | -148.333% |
Ampio Pharmaceuticals, Inc. | -10.67 USD | 86.036% |
Armata Pharmaceuticals, Inc. | -1.91 USD | 21.99% |
Actinium Pharmaceuticals, Inc. | -1.83 USD | 18.579% |
Azitra, Inc. | -54.76 USD | 97.279% |
Can-Fite BioPharma Ltd. | -1.79 USD | 16.76% |
Chromocell Therapeutics Corporation | -1.28 USD | -16.406% |
Calidi Biotherapeutics, Inc. | -1.73 USD | 13.873% |
CEL-SCI Corporation | -0.73 USD | -104.11% |
iBio, Inc. | -6.50 USD | 77.077% |
Lineage Cell Therapeutics, Inc. | -0.12 USD | -1141.667% |
Matinas BioPharma Holdings, Inc. | -5.28 USD | 71.78% |
Navidea Biopharmaceuticals, Inc. | -0.59 USD | -152.542% |
NovaBay Pharmaceuticals, Inc. | -138.65 USD | 98.925% |
NanoViricides, Inc. | -0.70 USD | -112.857% |
Oragenics, Inc. | -9.18 USD | 83.769% |
BiomX Inc. | -5.10 USD | 70.784% |
BiomX Inc. | -5.10 USD | 70.784% |
Protalix BioTherapeutics, Inc. | 0.12 USD | 1341.667% |
Palatin Technologies, Inc. | -2.02 USD | 26.238% |
Scorpius Holdings, Inc. | -347.20 USD | 99.571% |